News | April 08, 2021
Dr. Reddy's Laboratories launches Sapropterin Dihydrochloride powder for oral solution in US
Sapropterin dihydrochloride powder for oral solution is available in 100 mg unit dose
Sapropterin dihydrochloride powder for oral solution is available in 100 mg unit dose
The decision to withdraw the BLA is based on topline overall survival (OS) results from the confirmatory HERTHENA-Lung02 Phase 3 trial where OS did not meet statistical significance
Ideal for extreme dry skin and hyperkeratotic conditions such as psoriasis and ichthyosis, Ureaderm offers the next step in evidence-based, effective skin hydration
Previously, Sujatha has held leadership positions at prominent organizations, including Publicis Sapient, Infinite Computer Solutions, and Capgemini
Carson brings with him over two decades of experience in Communications, Public Affairs, and Sustainability
No safety signals related to the vaccine candidate were identified
The safety profile of Opdualag observed in this analysis was consistent with the known profiles of nivolumab and relatlimab
He also laid the foundation stone for a state-of-the-art 50-bedded Critical Care Block (CCB)
Accelerated approval is based on 61% overall response rate compared to 40% in control arm in the
Emraclidine was well-tolerated with an adverse event profile consistent with Phase 1b trial
Subscribe To Our Newsletter & Stay Updated
